Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat

作者: Shalea Piteau , Amy Olver , Su-Jin Kim , Kyle Winter , John Andrew Pospisilik

DOI: 10.1016/J.BBRC.2007.08.115

关键词:

摘要: In type 2 diabetes (T2DM) beta-cell responsiveness to glucose-dependent insulinotropic polypeptide (GIP) is reduced. a model of T2DM, the VDF Zucker rat, GIP receptor mRNA and protein levels were shown be down-regulated. Possible restoration in rats by reducing hyperglycemia has been examined. ZDF with extreme demonstrated greater islet down-regulation (94.3+/-3.8%) than ZF (48.8+/-22.8%). returned 83.0+/-17.9% lean following normalization phlorizin treatment pancreas perfusions markedly improved responsiveness. Treatment DP IV inhibitor (P32/98) resulted glucose tolerance restored sensitivity isolated pancreata. These findings support proposal that rodent T2DM secondary chronic glycemia can restore sensitivity.

参考文章(32)
Y.-T. Zhou, M. Shimabukuro, M.-Y. Wang, Y. Lee, M. Higa, J. L. Milburn, C. B. Newgard, R. H. Unger, Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 8898- 8903 ,(1998) , 10.1073/PNAS.95.15.8898
Jan A. Ehses, Vanbric R. Casilla, Tim Doty, J. Andrew Pospisilik, Kyle D. Winter, Hans-Ulrich Demuth, Raymond A. Pederson, Christopher H. S. McIntosh, Glucose-Dependent Insulinotropic Polypeptide Promotes β-(INS-1) Cell Survival via Cyclic Adenosine Monophosphate-Mediated Caspase-3 Inhibition and Regulation of p38 Mitogen-Activated Protein Kinase Endocrinology. ,vol. 144, pp. 4433- 4445 ,(2003) , 10.1210/EN.2002-0068
Francis C. Lynn, Stephen A. Thompson, J. Andrew Pospisilik, Jan A. Ehses, Simon A. Hinke, Nathalie Pamir, Christopher H. S. McIntosh, Raymond A. Pederson, A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells. The FASEB Journal. ,vol. 17, pp. 91- 93 ,(2003) , 10.1096/FJ.02-0243FJE
M A Nauck, M M Heimesaat, C Orskov, J J Holst, R Ebert, W Creutzfeldt, Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation. ,vol. 91, pp. 301- 307 ,(1993) , 10.1172/JCI116186
Andrea Trümper, Katja Trümper, Heidi Trusheim, Rudolf Arnold, Burkhard Göke, Dieter Hörsch, Glucose-Dependent Insulinotropic Polypeptide Is a Growth Factor for β (INS-1) Cells by Pleiotropic Signaling Molecular Endocrinology. ,vol. 15, pp. 1559- 1570 ,(2001) , 10.1210/MEND.15.9.0688
Hans-Christoph Fehmann, Burkhard Göke, Characterization of GIP(1–30) and GIP(1–42) as stimulators of proinsulin gene transcription Peptides. ,vol. 16, pp. 1149- 1152 ,(1995) , 10.1016/0196-9781(95)00090-7
Joel R. L. Ehrenkranz, Norman G. Lewis, C. Ronald Kahn, Jesse Roth, Phlorizin: a review. Diabetes-metabolism Research and Reviews. ,vol. 21, pp. 31- 38 ,(2005) , 10.1002/DMRR.532
Raphaël Roduit, Johane Morin, Frédéric Massé, Laura Segall, Enrique Roche, Christopher B. Newgard, Françoise Assimacopoulos-Jeannet, Marc Prentki, Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell * Journal of Biological Chemistry. ,vol. 275, pp. 35799- 35806 ,(2000) , 10.1074/JBC.M006001200
T. Vilsbøll, F. K. Knop, T. Krarup, A. Johansen, S. Madsbad, S. Larsen, T. Hansen, O. Pedersen, J. J. Holst, The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype The Journal of Clinical Endocrinology and Metabolism. ,vol. 88, pp. 4897- 4903 ,(2003) , 10.1210/JC.2003-030738